Examples of Coagulopathy
Coagulopathies are broadly classified into inherited and acquired disorders, with the most common inherited forms being hemophilia A (factor VIII deficiency), hemophilia B (factor IX deficiency), and von Willebrand disease, while the most common acquired forms are disseminated intravascular coagulation (DIC), liver disease, and vitamin K deficiency. 1, 2, 3
Inherited Coagulopathies
Most Common Inherited Disorders
- Hemophilia A (Factor VIII deficiency) is the most common severe inherited coagulation disorder, transmitted as an X-linked recessive trait, causing delayed deep bleeding into muscles and joints 4, 3, 5
- Hemophilia B (Factor IX deficiency) is clinically indistinguishable from hemophilia A and also follows X-linked recessive inheritance 4, 5
- Von Willebrand disease is the most common inherited coagulopathy overall, manifesting with mucocutaneous bleeding including easy bruising, epistaxis, menorrhagia, and prolonged bleeding after dental or surgical procedures 4, 5
Thrombophilic Inherited Disorders
- Protein C and S deficiencies are inherited as autosomal dominant traits and lead to increased risk of venous thrombosis, including cerebral venous thrombosis 1, 2, 6
- Factor V Leiden mutation increases thrombotic risk, particularly in younger patients, and is associated with venous rather than arterial thrombosis 1, 2, 6
- Prothrombin G20210A mutation similarly increases venous thrombotic risk 6
- Antithrombin III deficiency represents a major inherited thrombophilic risk factor 6
Critical caveat: These inherited thrombophilic disorders have NOT been strongly associated with arterial events such as myocardial infarction or ischemic stroke, despite their clear association with venous thromboembolism 1, 2
Rare Inherited Bleeding Disorders
- Inherited disorders of clotting factors V, VII, X, XI, and XIII are autosomal recessive traits that can lead to cerebral hemorrhage in childhood or the neonatal period 1, 2
- These rare factor deficiencies may only become clinically evident in homozygotes or compound heterozygotes 5
Acquired-Appearing Inherited Disorders
- Lupus anticoagulant and anticardiolipin antibodies can be familial in approximately 10% of cases, despite appearing to be acquired 1, 2
- Paradoxically, lupus anticoagulant predisposes to thrombosis rather than bleeding 7
Acquired Coagulopathies
Most Common Acquired Disorders
- Disseminated intravascular coagulation (DIC) is characterized by intravascular activation of coagulation with loss of localization, causing damage to microvasculature and potential organ dysfunction 8, 9, 3
- Liver disease causes coagulopathy through multiple mechanisms including decreased synthesis of coagulation factors, but paradoxically can also create a hypercoagulable state due to elevated factor VIII and von Willebrand factor with decreased protein C 10, 11, 7
- Vitamin K deficiency leads to decreased production of factors II, VII, IX, and X 7, 3
Disseminated Intravascular Coagulation Subtypes
DIC associated with cancer should be categorized into three clinically distinct subtypes: 9
- Procoagulant DIC presents with thrombosis (arterial ischemia, venous thromboembolism), commonly seen with pancreatic cancer and adenocarcinomas 9
- Hyperfibrinolytic DIC presents with widespread bleeding, classically seen in acute promyelocytic leukemia and metastatic prostate cancer 9
- Subclinical DIC shows laboratory markers of coagulation activation without obvious clinical manifestations 9
The ISTH overt-DIC diagnostic criteria include: decreased platelet count, prolonged prothrombin time, increased fibrin-related markers, and decreased fibrinogen, though notably these criteria do not include endothelium-related markers despite endothelial injury being essential to the DIC definition 8
Liver Disease Coagulopathy
Cirrhotic patients exhibit a paradoxical hypercoagulable state despite abnormal coagulation tests: 11
- Elevated factor VIII and von Willebrand factor coupled with decreased protein C drive hypercoagulability 11
- Traditional coagulation tests (PT/INR, aPTT) fail to capture this hypercoagulable state as they only measure procoagulant factors 11
- Critical pitfall: Do not rely on prolonged INR as evidence of bleeding risk; it systematically underestimates coagulation capacity in cirrhosis 11
- Prophylactic anticoagulation should not be withheld based solely on abnormal coagulation tests in hospitalized cirrhotic patients 11
Massive Transfusion Coagulopathy
- Coagulopathy in trauma patients differs from elective surgery, with uncontrolled tissue trauma, variable treatment intervals, frequent hypothermia and shock, and often progression to DIC 12
- Hypocalcemia develops during massive transfusion due to citrate in blood products binding calcium, impairing fibrin polymerization and platelet function 13
- Ionized calcium should be maintained >0.9 mmol/L during massive transfusion 13
Clinical Presentation Patterns
Bleeding Patterns by Disorder Type
- Primary hemostatic disorders (platelets and von Willebrand factor) cause mucocutaneous bleeding: epistaxis, menorrhagia, petechiae, easy bruising 4
- Secondary hemostatic disorders (coagulation factor deficiencies) cause delayed, deep bleeding into muscles and joints 4
Thrombotic Presentations
- Cortical vein thrombosis presents with headaches (71%), seizures (58%), and focal neurologic deficits (62%), with mean time to diagnosis of 7 days 6
- Cancer-associated procoagulant DIC manifests as arterial ischemia with patchy skin discoloration, poor digital circulation, cerebrovascular symptoms, peripheral neuropathy, ischemic colitis, or venous thromboembolism 9
Management Principles by Coagulopathy Type
Inherited Bleeding Disorders
- Preoperative treatment with desmopressin or factor replacement is required for invasive procedures to facilitate normal hemostasis 5
- Current lab values and hematology consultation are imperative prior to invasive dental or surgical treatment 5
Acquired Coagulopathies
- Liver disease: Fresh frozen plasma (FFP) contains all coagulation components physiologically balanced and is the appropriate substitution therapy; prothrombin complex concentrates should be used only in emergencies 7
- Vitamin K deficiency: Adequate vitamin K substitution is indicated 7
- DIC: Management primarily consists of aggressive treatment of the underlying disease; substitution therapy should be carefully monitored 7
- Massive transfusion: First-line treatment should be FFP to correct decreased coagulation factor levels, with an optimal plasma:red blood cell ratio of at least 1:2 13, 12
Critical contraindication: Heparin is contraindicated in uncontrolled active bleeding states, except when due to disseminated intravascular coagulation 14